Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3TCT

Structure of wild-type TTR in complex with tafamidis

Summary for 3TCT
Entry DOI10.2210/pdb3tct/pdb
Related2QGC 2QGD 2QGE
DescriptorTransthyretin, 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid (3 entities in total)
Functional Keywordsamyloid, amyloidosis, disease mutation, gamma-carboxyglutamic acid, glycoprotein, hormone, neuropathy, secreted, thyroid hormone, transport, kinetic stabilizer, inhibition of the amyloid cascade, binding protein
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P02766
Total number of polymer chains2
Total formula weight28170.95
Authors
Connelly, S.,Kelly, J.W.,Wilson, I.A. (deposition date: 2011-08-09, release date: 2012-05-30, Last modification date: 2023-09-13)
Primary citationBulawa, C.E.,Connelly, S.,Devit, M.,Wang, L.,Weigel, C.,Fleming, J.A.,Packman, J.,Powers, E.T.,Wiseman, R.L.,Foss, T.R.,Wilson, I.A.,Kelly, J.W.,Labaudiniere, R.
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Proc.Natl.Acad.Sci.USA, 109:9629-9634, 2012
Cited by
PubMed: 22645360
DOI: 10.1073/pnas.1121005109
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.3 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon